Antimicrobial susceptibility of Propionibacterium acnes isolates from acne patients in Colombia

International Journal of Dermatology

Volumn 52, Issue 6, 2013, Pages 688-692

  Mendoza, Natalia ^a,b   Hernandez, Paul O ^c   Tyring, Stephen K ^a,d   Haitz, Kassie A ^a   Motta, Adriana ^b  

^a CENTER FOR CLINICAL STUDIES   (United States)

^b UNIVERSIDAD EL BOSQUE   (Colombia)

^c University of Texas Health Science Center at San Antonio   (United States)

^d University of Texas Health Science Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOYL PEROXIDE; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; ISOTRETINOIN; MINOCYCLINE; RETINOIC ACID; SALICYLIC ACID; SPIRONOLACTONE; TETRACYCLINE;

ACNE; ACNE CONGLOBATA; ACNE CYSTICA; ACNE VULGARIS; ADOLESCENT; ADULT; AGAR DILUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACK; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHILD; CLINICAL EVALUATION; COLOMBIA; CROSS RESISTANCE; DISEASE SEVERITY; FACE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MINIMUM INHIBITORY CONCENTRATION; PREVALENCE; PROPIONIBACTERIUM ACNES; SCHOOL CHILD; THORAX; TREATMENT OUTCOME;

ACNE VULGARIS; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHILD; COLOMBIA; DERMATITIS; DRUG RESISTANCE, BACTERIAL; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; PREVALENCE; PROPIONIBACTERIUM ACNES; YOUNG ADULT;

EID: 84878116278     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2011.05403.x     Document Type: Article

References (25)

1. Strauss JS, Krowchuk DP, Leyden JJ, et al. Guidelines of care for acne vulgaris management. J Am Acad Dermatol 2007; 56: 651-663.
2. Tan HH, Tan AW, Barkham T, et al. Community-based study of acne vulgaris in adolescents in Singapore. Br J Dermatol 2007; 157: 547-551.
3. Ghodsi SZ, Orawa H, Zouboulis CC. Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study. J Invest Dermatol 2009; 129: 2136-2141.
4. Nijsten T, Rombouts S, Lambert J. Acne is prevalent but use of its treatments is infrequent among adolescents from the general population. J Eur Acad Dermatol Venereol 2007; 21: 163-168.
5. Collier CN, Harper JC, Cafardi JA, et al. The prevalence of acne in adults 20years and older. J Am Acad Dermatol 2008; 58: 56-59.
6. Dunn LK, O'Neill JL, Feldman SR. Acne in adolescents: quality of life, self-esteem, mood, and psychological disorders. Dermatol Online J 2011; 17: 1.
7. Roosta N, Black DS, Peng D, Riley LW. Skin disease and stigma in emerging adulthood: impact on healthy development. J Cutan Med Surg 2010; 14: 285-290.
8. Dessinioti C, Katsambas AD. The role of Propionibacterium acnes in acne pathogenesis: facts and controversies. Clin Dermatol 2010; 28: 2-7.
9. Patel M, Bowe WP, Heughebaert C, Shalita AR. The development of antimicrobial resistance due to the antibiotic treatment of acne vulgaris: a review. J Drugs Dermatol 2010; 9: 655-664.
10. Pechere JC. Patients' interviews and misuse of antibiotics. Clin Infect Dis 2001; 33(Suppl.): 170-173.
11. Ross JI, Snelling AM, Eady EA, et al. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the USA, Japan and Australia. Br J Dermatol 2001; 144: 339-346.
12. Coates P, Vyakrnam S, Eady EA, et al. Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study. Br J Dermatol 2002; 146: 840-848.
13. Burke BM, Cunliffe WJ. The assessment of acne vulgaris - the Leeds technique. Br J Dermatol 1984; 111: 83-92.
14. Engelkirk PG, Duben-Engelkirk JL. Anaerobic bacteria. In: Sabatini P, Dietz KC, Montalbano J, eds. Laboratory Diagnosis of Infectious Diseases: Essentials of Diagnostic Microbiology, 1st edn. Baltimore, MD: Lippincott Williams & Wilkins, 2008; 426.
15. National Committee for Clinical Laboratory Standards. Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standards, 6th edn. NCCLS M11-A6. Wayne, PA: Clinical and Laboratory Standards Institute, 2004.
16. Alekshun MN, Levy SB. Molecular mechanisms of antibacterial multidrug resistance. Cell 2007; 128: 1037-1050.
17. Ross JI, Eady EA, Carnegie E, Cove JH. Detection of transposon Tn5432-mediated macrolide-lincosamide-streptogramin B (MLSB) resistance in cutaneous propionibacteria from six European cities. J Antimicrob Chemother 2002; 49: 165-168.
18. Ross JI, Eady EA, Cove JH, et al. Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA. Antimicrob Agents Chemother 1997; 41: 1162-1165.
19. Ross JI, Eady EA, Cove JH, Cunliffe WJ. 16S rRNA mutation associated with tetracycline resistance in a gram-positive bacterium. Antimicrob Agents Chemother 1998; 42: 1702-1705.
20. El-Mahdy TS, Abdalla S, El-Domany R, et al. Detection of a new erm(X)-mediated antibiotic resistance in Egyptian cutaneous propionibacteria. Anaerobe 2010; 16: 376-379.
21. Oprica C, Lofmark S, Lund B, et al. Genetic basis of resistance in Propionibacterium acnes strains isolated from diverse types of infection in different European countries. Anaerobe 2005; 11: 137-143.
22. Ross JI, Snelling AM, Carnegie E, et al. Antibiotic-resistant acne: lessons from Europe. Br J Dermatol 2003; 148: 467-478.
23. Rodriguez-Cavallini E, Vargas-Dengo P. [Bacterial etiology and antibiotic susceptibility in patients with acne]. Rev Biomed 2004; 15: 101-106.
24. Gubelin W, Martinez MA, Molina MT, et al. [Antimicrobial susceptibility of strains of Propionibacterium acnes isolated from inflammatory acne]. Rev Latinoam Microbiol 2006; 48: 14-16.
25. Gonzalez R, Welsh O, Ocampo J, et al. In vitro antimicrobial susceptibility of Propionibacterium acnes isolated from acne patients in northern Mexico. Int J Dermatol 2010; 49: 1003-1007.